Innovation and The Israel Journal of Health Policy Research

The IJHPR is simultaneously a national journal and an international journal. Many journals, such as Health Policy and the International Journal on Equity in Health Care are fundamentally international in nature. Others, such as the Canadian Health Policy Journal or Health Affairs have a clear focus on a particular country with, perhaps, an occasional article about another country. The IJHPR is uncommon in that it seeks to inform the development of health policy both within a specific country (Israel) and globally.¹ According to Thomson-Reuters (personal communication), this dual nature was one of the primary factors in its 2013 decision to include the IJHPR in its Web of Science database in the IJHPR’s second year of existence – an unusual step by this prestigious bibliographic database. The journal’s innovative positioning has also contributed to annual growth of over 20% in both submissions and publications.

In light of its dual nature,² it is not surprising that about one-half of the articles published to date have included at least one author from a non-Israeli institution.³ Figure 2 highlights the non-Israeli institutions that are associated with the most IJHPR articles. These include institutions from the US, UK, and Canada.

Figure 3 highlights the Israeli institutions associated with the most IJHPR articles.⁴ The fact that authors from the Ministry of Health have been frequent contributors is particularly noteworthy, and reflects the journal’s strong policy orientation. A broader analysis, not reflected in the chart, found that the IJHPR had a significant volume of contributions from virtually all of the Israeli universities, research centers, hospitals, health plans, and government agencies involved in health care.

In addition to being an innovative platform, the IJHPR also serves in several ways as a platform for innovation and for the dissemination of innovations. As such, the journal continues to be a platform for innovations in writing and publishing that were not envisioned at the time of the journal’s establishment.

It is an excellent platform for sharing with the international community Israeli innovations in health policy and health care. For example, in 2012, a group based at the Hebrew University shared some of the accomplishments of Israel’s innovative system for monitoring quality of care in community-based health services [8]. Two years later, a group based at the Ministry of Health and the Gertner Center, shared an innovative Israeli approach to grappling with the ethical challenges posed by an important technological advance – the ability to use pre-implantation genetic diagnoses as a tool for sex selection [10]. And, in 2017, the IJHPR published an article from a group based at the Ministry of Health about how Israel is addressing the challenge of drug shortages – an issue relevant to many countries around the world [15].

The IJHPR is also being used to bring international perspectives to bear on important health system developments in Israel. After publishing empirical studies about an Israeli health care phenomenon or development, the editors often turn to international leaders in the relevant field and invite them to write a commentary on the Israeli study. For example, one of our commentaries was written by Alvin Roth, a Nobel laureate in economics. His commentary related to an Israeli paper that proposed a new way to assign young physicians to internships [13].

Oftentimes the commentaries are used to highlight the international significance of an Israeli study. This was the case, for example, in a commentary by Daniel Cotlear, the manager of the World Bank’s Universal Health Coverage Support Program [4]. Cotlear had read an IJHPR integrative article by two senior professionals from the Israel Ministry of Health analyzing Israel’s strategy for reducing health disparities [5], and felt that the Israeli experience could be very relevant and informative for a wide range of middle-income countries.

At other times, commentators use the international experience to suggest possible next steps for Israel – either in terms of program/policy development or in terms of research. For example, one of our commentators used her experience as an executive at the Visiting Nurse Service of New York to recommend potential strategies that Israel might adopt to provide a stronger support system for home care workers, more fully integrate them into the care team, and improve the occupational health and safety of this diverse, rapidly expanding workforce [14]. Similarly, an organizational consultant based in Toronto, writing a commentary on an Israeli paper about patient-initiated violence in hospitals, noted that Israel also need to address passive-aggressive and other low-level rude behaviors that take place frequently amongst hospital personnel [1].

The IJHPR has also encouraged a growing number of Israeli scholars to analyze and write about policy development in Israel. The topics have included tobacco control policy [12], policy related to drug use among Israeli backpackers [3], and efforts to reduce health disparities [5]. We believe it is important that such analyses be done and be published. Yet, if not for the existence of the IJHPR, it is unlikely that English language analyses of this sort would have been written; and even if they had been written, it would have been difficult to get them published in other peer-reviewed journals due to their focus on a specific, relatively small, country. Nonetheless, they contribute greatly to policy development in Israel and also contribute to comparative cross-national analyses. Thus, we see encouragement of these analyses and their publication as both innovative and important.

The IJHPR has also developed a large and growing set of article collections which bring together Israeli and non-Israeli writings on a specific topic.⁵ Our oldest and largest collections deal with the healthcare workforce (over 80 articles) and health promotion/disease prevention (over 70 articles). The newer collections include digital health, mental health, and pharmaceutical policy. The full list of collections can be found in Fig. 4. The on-line nature of the journal makes it easy to launch a collection with just a limited number of articles and then expand it over time. These collections are being used extensively for teaching purposes and for the writing and reviewing of grant proposals and journal articles.

The IJHPR also facilitates wide dissemination of key messages for health policy workshops and conferences held in Israel. These publications typically take the form of meeting reports, as has been the case for workshops on private health insurance [2], professionalism in the practice of medicine [9], and the potential role of the Holocaust in physician education [11]. Within less than 2 weeks after the IJHPR published the third mentioned report, it had been picked up by Richard Horton, the editor of “The Lancet,” one of the most widely read medical journals in the world, who wrote a commentary about it for his journal, entitled, “Medicine and the Holocaust—it’s time to teach” [6].

Another publication format related to meetings is publication of a supplement with the abstracts from the papers presented at a conference. The IJHPR did this recently with regard to the Jerusalem International Health Policy Conference on health care innovation [7].

The IJHPR is also an important and innovative vehicle of communication among Israeli researchers and between Israeli researchers and Israeli policymakers. As such, it facilitates new types of interactions and collaborations among them.

Finally, we are extremely proud that the IJHPR has published approximately 50 papers involving collaborations between an author based primarily at an Israeli institution and an author based at a non-Israeli institution. One such paper compared Israeli and Austrian regulation of egg cell donations [16]. It is by far the journal’s most downloaded article. We consider collaborative articles to be very important and plan to publish more of them in the months and years ahead.